Enrolling By Invitation NA INTERVENTIONAL 1-arm NCT06904846

To Evaluate the Change in Glucose Parameters in Adult Patients With Type 1 or Type 2 Diabetes From Europe Using the iCan o3 CGM System for 60 Days Period (DETECT)

Prospective Post-market Clinical Follow-up (PMCF) Study Aimed to Evaluate the Change in Glucometric Parameters in Adult Patients With Type 1 or Type 2 DiabETes From Europe Using the iCan o3 CGM SysTem for a 60-day Period

Sponsor: Archer Research

Conditions Continuous Glucose Monitoring System Diabetes Mellitus

Interventions iCan o3 CGM Continuous Glucose Monitoring System

Updated 3 times since 2025 Last updated: Jan 13, 2026 Started: Apr 23, 2025 Primary completion: Apr 30, 2026 Completion: Jun 30, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Continuous Glucose Monitoring System and Diabetes Mellitus, this trial is ongoing. The trial is conducted by Archer Research and has accumulated 3 data snapshots since 2025. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

3 versions recorded

Feb 2026 — Present [monthly]

Enrolling By Invitation NA
Jun 2025 — Feb 2026 [monthly]

Enrolling By Invitation NA

Status: Not Yet Recruiting → Enrolling By Invitation
May 2025 — Jun 2025 [monthly]

Not Yet Recruiting NA

First recorded

Apr 2025

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Archer Research
Sinocare

Data source: Sinocare

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Antwerp, Belgium